Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells.

Bandobashi K, Liu A, Nagy N, Kis LL, Nishikawa J, Björkholm M, Klein G, Klein E.

Virus Genes. 2005 May;30(3):323-30.

PMID:
15830149
2.
3.

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.

Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.

J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18.

PMID:
22921685
4.

In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.

Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E.

Int J Cancer. 2005 Mar 1;113(6):937-45.

5.
6.

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

Kis LL, Takahara M, Nagy N, Klein G, Klein E.

Immunol Lett. 2006 Apr 15;104(1-2):83-8. Epub 2005 Dec 1. Review.

PMID:
16386314
9.

Infection of leukaemic B lymphocytes by Epstein Barr virus.

Doyle MG, Catovsky D, Crawford DH.

Leukemia. 1993 Nov;7(11):1858-64.

PMID:
8231253
10.
11.

Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.

Jiménez-Ramírez C, Brooks AJ, Forshell LP, Yakimchuk K, Zhao B, Fulgham TZ, Sample CE.

J Virol. 2006 Nov;80(22):11200-8. Epub 2006 Sep 6.

12.
13.

Restricted expression of EBV encoded proteins in in vitro infected CLL cells.

Klein E, Nagy N.

Semin Cancer Biol. 2010 Dec;20(6):410-5. doi: 10.1016/j.semcancer.2010.10.013. Epub 2010 Oct 27. Review.

PMID:
21034831
14.

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.

J Virol. 1988 Oct;62(10):3747-55.

15.

C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.

Cancian L, Bosshard R, Lucchesi W, Karstegl CE, Farrell PJ.

PLoS Pathog. 2011 Jul;7(7):e1002164. doi: 10.1371/journal.ppat.1002164. Epub 2011 Jul 28.

16.

LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40.

Klein E, Teramoto N, Gogolák P, Nagy N, Björkholm M.

Immunol Lett. 1999 May 3;68(1):147-54. Review.

PMID:
10397170
18.

Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.

Young LS, Finerty S, Brooks L, Scullion F, Rickinson AB, Morgan AJ.

J Virol. 1989 May;63(5):1967-74.

20.

Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle.

Teramoto N, Gogolák P, Nagy N, Maeda A, Kvarnung K, Björkholm T, Klein E.

J Hum Virol. 2000 May-Jun;3(3):125-36.

PMID:
10881992

Supplemental Content

Support Center